The plain-language read
Rosacea is a multifactorial inflammatory skin disease involving neurovascular dysregulation, innate immune hyperactivity (cathelicidin), Demodex mite overgrowth, and barrier dysfunction. Standard-of-care includes ivermectin 1% cream (for papulopustular subtype), brimonidine 0. 33% gel (for erythematotelangiectatic), oral doxycycline 40mg, and topical metronidazole.
- Multifactorial pathogenesis requires multi-pronged therapy
- Subantimicrobial doxycycline (40mg) achieves anti-inflammatory benefit without resistance
- Trigger avoidance (heat, alcohol, sun, spice) is non-negotiable
- Barrier support is foundational — gentle cleansing, ceramides, daily SPF
Build a rosacea protocol on barrier support first, then layer subtype-appropriate prescription therapy. Skip exfoliating acids and strong retinoids during flares.
What this means for your routine
If you're targeting rosacea, this research supports adding ivermectin to your AM/PM routine. Effective concentration range: 1% based on this study.
If you're targeting rosacea, this research supports adding metronidazole to your AM/PM routine. Effective concentration range: 1% based on this study.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
Rosacea involves neurovascular dysregulation, cathelicidin/KLK5 overexpression, Demodex folliculorum density, and impaired barrier. Subtype-specific therapy: ivermectin 1% for papulopustular, brimonidine 0.33% gel for ETR, oral subantimicrobial doxycycline (40mg MR), topical metronidazole and azelaic acid as foundations.
Full abstract→
Rosacea is a multifactorial inflammatory skin disease involving neurovascular dysregulation, innate immune hyperactivity (cathelicidin), Demodex mite overgrowth, and barrier dysfunction. Standard-of-care includes ivermectin 1% cream (for papulopustular subtype), brimonidine 0.33% gel (for erythematotelangiectatic), oral doxycycline 40mg, and topical metronidazole. Lifestyle triggers (heat, alcohol, spicy food, sun) must be co-managed.
Original source →Changes in ultraviolet a radiation-induced thymidine dimers and erythema after oral nicotinamide or polypodium leucotomos extract in healthy volunteers: a randomized intraindividual trial.
Nicotinamide (NAM) and Polypodium leucotomos extract (PL) have demonstrated photoprotective effects, but their role in preventing UVA-induced DNA damage in humans remains unclear. To evaluate the effects of oral NAM and PL on UVA-induced erythema and thymidine dimer (TT-dimer) formation. In this intraindividual trial, 50 healthy volunteers (phototypes I-III) were randomized (1:1) to receive either NAM (2000 mg daily) or PL (Heliocare Advanced: 480 mg daily) for 30 days.
Iontophoresis-Based Topical Drug Delivery for Dermatologic Conditions: A Systematic Review.
The efficacy of topical therapies in dermatology is often limited by the barrier function of the stratum corneum, which restricts drug penetration. Iontophoresis is a non-invasive transdermal delivery technique that uses a low-intensity electrical current to enhance the transport of charged and polar molecules across the skin. It has emerged as a strategy to improve local drug bioavailability while minimizing systemic exposure.
Effects of diacylglycerol-enriched alpha-linolenic acid oil on skin properties in mild skin discomfort: a randomized, double-blind, placebo-controlled study.
satoko@kao. Skin barrier function impairment and inflammation promote allergen invasion through the skin, leading to sensitization and exacerbation of allergic diseases. Intake of linseed oil, an oil rich in alpha-linolenic acid (ALA), suppresses inflammation and allergic symptoms.